Renaissance Technologies’s Karyopharm Therapeutics KPTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$284K Buy
65,814
+4,600
+8% +$19.8K ﹤0.01% 3061
2025
Q1
$229K Sell
61,214
-18,959
-24% -$70.9K ﹤0.01% 3040
2024
Q4
$813K Sell
80,173
-2,587
-3% -$26.2K ﹤0.01% 2601
2024
Q3
$1.03M Buy
82,760
+32,345
+64% +$403K ﹤0.01% 2429
2024
Q2
$656K Sell
50,415
-10,038
-17% -$131K ﹤0.01% 2554
2024
Q1
$1.37M Sell
60,453
-70,505
-54% -$1.6M ﹤0.01% 2278
2023
Q4
$1.7M Buy
130,958
+82,265
+169% +$1.07M ﹤0.01% 2052
2023
Q3
$979K Buy
48,693
+4,200
+9% +$84.4K ﹤0.01% 2315
2023
Q2
$1.2M Sell
44,493
-4,554
-9% -$122K ﹤0.01% 2361
2023
Q1
$2.86M Buy
49,047
+36,427
+289% +$2.13M ﹤0.01% 1800
2022
Q4
$644K Sell
12,620
-7,933
-39% -$405K ﹤0.01% 2795
2022
Q3
$1.68M Sell
20,553
-9,767
-32% -$800K ﹤0.01% 2133
2022
Q2
$2.05M Buy
30,320
+15,980
+111% +$1.08M ﹤0.01% 2170
2022
Q1
$1.59M Buy
14,340
+8,613
+150% +$952K ﹤0.01% 2410
2021
Q4
$552K Sell
5,727
-27,300
-83% -$2.63M ﹤0.01% 3029
2021
Q3
$2.88M Buy
33,027
+31,796
+2,583% +$2.78M ﹤0.01% 1813
2021
Q2
$191K Buy
+1,231
New +$191K ﹤0.01% 3256
2020
Q3
Sell
-12,120
Closed -$3.44M 3531
2020
Q2
$3.44M Sell
12,120
-23,480
-66% -$6.67M ﹤0.01% 1854
2020
Q1
$10.3M Buy
35,600
+24,900
+233% +$7.17M 0.01% 1145
2019
Q4
$3.08M Buy
+10,700
New +$3.08M ﹤0.01% 2112
2019
Q3
Sell
-4,901
Closed -$440K 3571
2019
Q2
$440K Sell
4,901
-56,352
-92% -$5.06M ﹤0.01% 3043
2019
Q1
$5.37M Buy
61,253
+32,836
+116% +$2.88M ﹤0.01% 1761
2018
Q4
$3.99M Buy
28,417
+23,704
+503% +$3.33M ﹤0.01% 1861
2018
Q3
$1.2M Sell
4,713
-4,480
-49% -$1.14M ﹤0.01% 2529
2018
Q2
$2.34M Buy
+9,193
New +$2.34M ﹤0.01% 2187